LOGIN
No significant mean changes in hand grip and vigor from baseline between use of EPO and PA
August 2013
No significant mean changes in hand grip and vigor from baseline between use of EPO and PA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
A Randomized, Parallel-Group, Open-Label Trial of Recombinant Human Erythropoietin vs Preoperative Autologous Donation in Primary Total Joint Arthroplasty
J Arthroplasty. 2007 Apr;22(3):325-33Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
251 patients undergoing primary unilateral total knee or hip arthroplasty were randomly assigned to receive treatment of either erythropoietin (EPO) or preoperative autologous donation (PAD) to examine the outcomes of vigor scores and hand grip strength. Results showed that mean changes in the outcomes of handgrip and vigor from baseline were not significantly different between the PAD or EPO trea...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.